158 related articles for article (PubMed ID: 5125674)
1. Some aspects of the immune defense against cancer. II. In vitro studies on human tumors.
Hellström I; Hellström KE
Cancer; 1971 Nov; 28(5):1269-71. PubMed ID: 5125674
[No Abstract] [Full Text] [Related]
2. Some aspects of the immune defense against cancer. I. In vitro studies on animal tumors.
Hellström KE; Hellström I
Cancer; 1971 Nov; 28(5):1266-8. PubMed ID: 5125673
[No Abstract] [Full Text] [Related]
3. The immunology of tumors.
Burk MW; Mckhann CF
Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
[No Abstract] [Full Text] [Related]
4. Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms.
Hellström I; Hellström KE
Cancer; 1974 Oct; 34(4 Suppl):suppl:1461-8. PubMed ID: 4417442
[No Abstract] [Full Text] [Related]
5. Approaches to immunotherapy.
McKhann CF; Gunnarsson A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1521-31. PubMed ID: 4608719
[No Abstract] [Full Text] [Related]
6. The immunology of cancer.
Angel Basombrío M
J Oral Pathol; 1973; 2(5):231-53. PubMed ID: 4207800
[No Abstract] [Full Text] [Related]
7. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
Hellström I; Warner GA; Hellström KE; Sjögren HO
Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
[No Abstract] [Full Text] [Related]
8. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
[TBL] [Abstract][Full Text] [Related]
9. Cellular immunity and blocking antibodies to tumors.
Hellström I; Hellström KE
J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
[No Abstract] [Full Text] [Related]
10. [Immunologic reactions in malignant melanoma of the skin in man].
Veresova OV; Korosteleva TA
Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
[No Abstract] [Full Text] [Related]
11. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
12. [Immunological approaches to the treatment of solid tumors].
May-Levin F
Boll Ist Sieroter Milan; 1971; 50(3):221-30. PubMed ID: 4111987
[No Abstract] [Full Text] [Related]
13. Immunity to neuroblastomas and melanomas.
Hellström KE; Hellström I
Annu Rev Med; 1972; 23():19-38. PubMed ID: 4566479
[No Abstract] [Full Text] [Related]
14. Immunologic defenses against cancer.
Bernstein ID
J Pediatr; 1973 Dec; 83(6):906-18. PubMed ID: 4585830
[No Abstract] [Full Text] [Related]
15. Some recent studies on cellular immunity to human melanomas.
Hellström I; Hellström KE
Fed Proc; 1973 Feb; 32(2):156-9. PubMed ID: 4120196
[No Abstract] [Full Text] [Related]
16. Aspects of immunology in radiotherapy.
James KW
Mod Trends Radiother; 1972; 2():77-97. PubMed ID: 4563804
[No Abstract] [Full Text] [Related]
17. [Immunological exploration of cancer patients. II. Tumoral immunity].
Cappelaere P; Demaille A; Adenis L
Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
[No Abstract] [Full Text] [Related]
18. Prospects for the immunotherapy of cancer. Part I: Basic concepts of tumor immunology.
Pilch YH; Myers GH; Sparks FC; Golub SH
Curr Probl Surg; 1975 Jan; ():1-46. PubMed ID: 236150
[No Abstract] [Full Text] [Related]
19. [Evidence for tumor immunity in human malignant melanoma].
Nagel GA
Schweiz Med Wochenschr; 1970 Jun; 100(23):995-1000. PubMed ID: 4947017
[No Abstract] [Full Text] [Related]
20. Serum inhibitors of cellular immunity in human neuroblastoma. IgG subclass of blocking activity.
Jose DG; Skvaril F
Int J Cancer; 1974 Feb; 13(2):173-8. PubMed ID: 4856316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
